
Orvispas P Oral Suspension
Marketer
Orville Biotek
Salt Composition
Mefenamic Acid (50mg) + Paracetamol (125mg)
Overview Orvispas P Oral Suspension
Orvispas P Oral Suspension, a pediatric formulation, combines two active components within the non-steroidal anti-inflammatory drug (NSAID) class. This medication effectively reduces fever and alleviates pain and inflammation (swelling and redness) in infants and children. Administer Orvispas P Oral Suspension precisely as directed, ideally at the same time each day. While it can be given with or without food, post-meal administration may minimize stomach upset. If your child vomits within 30 minutes, repeat the dose. Exceeding the recommended dosage for quicker results may lead to adverse reactions. Minor side effects, such as nausea, vomiting, abdominal discomfort, indigestion, and diarrhea, may occur; these are usually transient. However, persistent or troubling side effects necessitate immediate consultation with your pediatrician. Before administering Orvispas P Oral Suspension, disclose any known drug allergies, pre-existing heart conditions, congenital defects, liver impairment, kidney disease, respiratory issues, or bleeding disorders. This information is crucial for accurate dosage and optimal treatment planning.
Uses of Orvispas P Oral Suspension
Alleviating pain and reducing fever
Major Benefits of Orvispas P Oral Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Consult the product label for complete instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Orvispas P Oral Suspension can be consumed with or without food; however, consistent timing is recommended.
Common Side effects of Orvispas P Oral Suspension:
- Nausea
- Vomiting
- Abdominal pain
- Heartburn
- Diarrhea
- Dizziness
How to use Orvispas P Oral Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Always consult the product label for detailed instructions prior to ingestion. Use a measuring device to accurately dispense the oral suspension and swallow it. Ensure thorough shaking before each use. Orvispas P Oral Suspension can be consumed with or without food; however, consistent timing is recommended for optimal results.
How Orvispas P Oral Suspension works:
Orvispas P Oral Suspension, a formulation combining mefenamic acid and paracetamol, employs two non-steroidal anti-inflammatory drugs (NSAIDs) to alleviate symptoms. Its mechanism involves inhibiting the production of inflammatory mediators responsible for fever, pain, and the associated swelling and redness.
SAFETY ADVICE
KidneyCAUTION
Patients with kidney impairment should use Orvispas P Oral Suspension cautiously, potentially requiring dosage modification. Physician consultation is advised. Orvispas P Oral Suspension is contraindicated in children exhibiting severe kidney disease.
LiverSAFE IF PRESCRIBED
Orvispas P Oral Suspension presents no known safety concerns for individuals with hepatic impairment; dosage modification is unnecessary. However, prolonged Orvispas P Oral Suspension use in pediatric patients warrants routine monitoring of liver function via liver function tests (LFTs).
What if you forget to take Orvispas P Oral Suspension :
Remain calm. Administer the forgotten dose immediately upon recollection. Omit the missed dose, however, if the next dose is due, or if your pediatrician has advised against taking missed doses. Avoid doubling the dose; adhere strictly to the recommended dosage regimen.
Facts to Know About Orvispas P Oral Suspension
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Pain Relief Medications |
